Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Bull4u2on Apr 13, 2018 4:21pm

68 Views

Post# 27882542

RE:RE:Eagerly Waiting

Boy, whatever happened to all of the excitement from big pharma? Was that all just speculative banter? This is getting worse than watching paint dry. How many more months before they actually come out with some news? If it's such a formality, why the F*ck isn't it done.

elgin1 wrote: Yes totally agree IRB is just a formality ..... but announcements for trial starting should be positive . Perhaps it will encourage progress on pharma collaboration front to get moving . I think Irb meets next week so fingers crossed.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario